During the 59th National Ophthalmology Congress, our
team had the opportunity to present the latest clinical
findings and technological developments related to the
Magnovision™ device.
The presentation, delivered by Umut Arslan, focused on:
Advancements in non-invasive magnetic stimulation
technology
Clinical outcomes observed in retinal and optic
nerve disorders
OCT-based monitoring of structural recovery
Practical insights from ongoing patient applications
Future directions and research collaborations
This congress marks an important milestone in sharing
our scientific progress with ophthalmology specialists
across Türkiye.
We continue our mission to develop innovative, safe,
and clinically effective solutions for retinal and optic
nerve rehabilitation.
